Schistosomiasis: Forty years' war on the worm

Parasitology Today

Volumn 14, Issue 10, 1998, Pages 379-384

  Capron, A ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; PRAZIQUANTEL; RECOMBINANT ENZYME; SCHISTOSOMA VACCINE;

CHROMOSOME MAP; EGG PRODUCTION; GENE EXPRESSION; HOST PARASITE INTERACTION; HUMAN; IMMUNITY; LIFE CYCLE; MOLECULAR CLONING; MOLLUSC; NONHUMAN; REVIEW; SCHISTOSOMIASIS; SEQUENCE ANALYSIS; SEX DIFFERENTIATION;

EID: 0031795928     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(98)01322-2     Document Type: Article

References (52)

1. World Health Organization, WHO Fact Sheet 115, May 1996.
2. Bergquist R.N., Colley D.G. Schistosomiasis vaccines: research to development. Parasitol. Today. 14:1998;99-104.
3. Stelma F.F.et al. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 53:1995;167-170.
4. Fallon P.G.et al. Diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 53:1995;61-62.
5. Ismail M.et al. Characterization of isolates of Schistosoma mansoni from Egyptian villages that tolerate high doses of praziquantel. Am. J. Trop. Med. Hyg. 55:1996;214-218.
6. Capron A. Immunity to schistosomes. Curr. Opin. Immunol. 4:1992;419-424.
7. Pearce, E.J. (1995) in Molecular Approaches to Parasitology, pp 497-510, Wiley-Liss.
8. Dunne D.W., Hagan P., Abath F.G.C. Prospects for immunological control of schistosomiasis. Lancet. 345:1995;1488-1491.
9. McCarthy J., Nutman T. Perspective: prospects for development of vaccines against human helminth infections. J. Infect. Dis. 174:1996;1384-1390.
10. Newport, E.R. and Colley, D.G. (1993) in Immunology and Molecular Biology of Parasitic Infections (Warren, K., ed.), pp 387-437, Blackwell Scientific Publications.
11. McNair A.et al. Cloning and characterization of the gene encoding the 28 Kd gluthatione-S-transferase of Schistosoma mansoni. Gene. 124:1993;245-249.
12. Dissous C., Capron A. Convergent evolution of tropomyosin epitopes. Parasitol. Today. 11:1995;45-46.
13. Damian R.T. Molecular mimicry revisited. Parasitol. Today. 3:1987;263-266.
14. Capron A. Le langage moléculaire des parasites. Med. Sci. 11:1995;431-439.
15. Maizels R.M.et al. Immunological modulation and evasion by helminth parasites in human populations. Nature. 365:1993;797-805.
16. Dissous C., Grzych J.M., Capron A. Schistosoma mansoni shares a protective oligosaccharide epitope with freshwater and marine snails. Nature. 323:1986;443-445.
17. Duvaux-Miret O.et al. Immunosuppression in the definitive and intermediate hosts of the human parasite Schistosoma mansoni by release of immunoactive neuropeptides. Proc. Natl. Acad. Sci. U. S. A. 89:1982;778-781.
18. Yoshino T.P., Laursen J.R. Production of Schistosoma mansoni daughter sporocysts from mother sporocytes maintained in synxenic culture with Biomphalaria glabrata embryonic (Bge) cells. J. Parasitol. 81:1995;714-722.
19. Lardans V.et al. DNA transfer in a Biomphalaria embryonic cell line by DoTAP lipofection. Parasitol. Res. 82:1996;574-576.
20. Marquet S.et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat. Genet. 14:1996;181-184.
21. Deelder A.M.et al. Sensitive determination of circulating anodic antigen in Schistosoma mansoni infected individuals by an enzyme linked immunosorbent assay using monoclonal antibodies. Am. J. Trop. Med. Hyg. 40:1989;268-272.
22. + T cell subsets. Proc. Natl. Acad. Sci. U. S. A. 91:1994;18-22.
23. Grzych J.M.et al. An anti-idiotype vaccine against experimental schistosomiasis. Nature. 396:1985;74-76.
24. Capron M., Capron A. Rats, mice and men: models for immune effector mechanisms against schistosomiasis. Parasitol. Today. 2:1986;69-75.
25. Capron A., Dessaint J.P. Effector and regulatory mechanisms in immunity to schistosomes: a heuristic view. Annu. Rev. Immunol. 3:1985;455-476.
26. Capron A.et al. Immunity to schistosomes: progress towards vaccine. Science. 238:1987;1065-1072.
27. Capron A., Dessaint J.P. Immunologic aspects of schistosomiasis. Annu. Rev. Med. 43:1992;209-218.
28. Capron M., Capron A. Immunoglobulin E and effector cells in schistosomiasis. Science. 264:1994;1876-1877.
29. Verwaerde C.et al. Functional properties of a rat monoclonal IgE antibody specific for Schistosoma mansoni. J. Immunol. 138:1987;4441-4446.
30. Hagan P.et al. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature. 369:1991;243-245.
31. Rihet P.et al. Evidence for an association between human resistance to Schistosoma mansoni and high anti larval IgE levels. Eur. J. Immunol. 21:1991;2679-2686.
32. Dunne D.W.et al. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur. J. Immunol. 22:1992;1483-1494.
33. James S.L., Sher A. Cell mediated immune response to schistosomiasis. Curr. Top. Microbiol. Immunol. 155:1980;21-41.
34. Smythies L.E., Coulson P., Wilson R.A. Monoclonal antibody to IFN-γ modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with irradiated cercariae. J. Immunol. 149:1992;3654-3658.
35. Grzych J.M.et al. Blocking activity of rat monoclonal antibodies in experimental schistosomiasis. J. Immunol. 133:1984;998-1004.
36. Khalife J.et al. Immunity in human Schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodies. J. Exp. Med. 166:1986;1626-1640.
37. Auriault C.et al. Antibody response of Schistosoma mansoni infected human subjects to the recombinant P28 glutathione-S-transferase and to synthetic peptides. J. Clin. Microbiol. 98:1980;1918-1924.
38. Demeure C.E.et al. Resistance to Schistosoma mansoni in humans: influence of IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J. Infect. Dis. 168:1991;1000-1008.
39. + T cell response to Schistosoma mansoni. Exp. Parasitol. 73:1991;110-116.
40. Roberts M.et al. Immunity after treatment of schistosomiasis: association between cellular responses and resistance to reinfection. Infect. Immunol. 61:1993;4984-4993.
41. Pearce E.J.et al. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J. Exp. Med. 173:1991;159-166.
42. Wynn T.A.et al. An IL-12 based vaccination method for preventing fibrosis induced by schistosome infection. Nature. 376:1995;594-596.
43. Fulford A.S.C.et al. Puberty and age related changes in susceptibility to schistosome infection. Parasitol. Today. 14:1998;22-26.
44. Chan M.S., Woolhouse M.E.S., Bundy D.A.P. Human schistosomiasis: potential long term consequences of vaccination programmes. Vaccine. 15:1997;1545-1550.
45. Caulada-Benedetti Z.et al. Comparison of Th1 and Th2 associated immune reactivities stimulated by single versus multiple vaccination of mice with associated Schistosoma mansoni cercariae. J. Immunol. 146:1991;1655-1660.
46. Riveau, G.J. and Capron, A. (1996) in Concepts in Vaccine Development (Kaufman, S., ed.), pp 509-532, Walter de Gruyter.
47. Waine E.J., McManus D.P. Schistosomiasis vaccine development. The current picture. BioEssays. 19:1997;435-443.
48. Balloul J.M.et al. Molecular cloning of a protective antigen of schistosomiasis. Nature. 326:1987;149-153.
49. Capron A.et al. Development of a vaccine strategy against human and bovine schistosomiasis. Background and update. Trop. Geogr. Med. 46:1994;242-246.
50. Grzych J.M.et al. IgA antibodies to a protective antigen in human schistosomiasis mansoni. J. Immunol. 150:1993;527-535.
51. Boulanger D.et al. Vaccination of patas monkeys experimentally infected with Schistosoma haematobium using a recombinant glutathione-S-transferase cloned from S. mansoni. Parasite Immunol. 17:1995;301-309.
52. Agnew A.et al. Age-dependent reduction of schistosome fecundity in Schistosoma haematobium but not Schistosoma mansoni in humans. Ann. J. Trop. Med. Hyg. 55:1996;338-343.